ASP Isotopes unit QLE signs HALEU joint venture agreement with South Africa's Necsa
Quantum Leap Energy, a wholly owned subsidiary of ASP Isotopes, signed a Heads of Agreement with South Africa's Nuclear Energy Corporation (Necsa) that sets a binding commercial framework for a joint venture to produce High-Assay Low-Enriched Uranium at Necsa's Pelindaba site. The filing gives no financial value or capital commitment for the venture, so its effect on shareholders is not quantified.
Key points
- QLE would hold approximately 80% of the joint venture and lead operations and capital arrangements; Necsa would hold approximately 20%.
- The joint venture would develop, finance, construct, commission, own and operate a test bench and commercial-scale HALEU facility at Pelindaba, South Africa.
- QLE has offtake for the expected HALEU output through supply agreements with TerraPower.
- South Africa's Ministry of Electricity and Energy approved QLE's source material and equipment activities at Pelindaba in July 2026.
The filing
Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 15, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.